Although currently available drugs are useful in controlling early onset complications of diabetes, serious late onset complications appear in a large number of patients. Considering the physiopathology of diabetes, preventing beta cell degeneration and stimulating the endogenous regeneration of islets will be essential approaches for the treatment of insulin-dependent diabetes mellitus.
This report elaborates the market size, market characteristics, and market growth of the Pancreatic Beta-Cell Protection industry, and breaks down according to the type, application, and consumption area of Pancreatic Beta-Cell Protection. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pancreatic Beta-Cell Protection in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Pancreatic Beta-Cell Protection market covered in Chapter 13:
Pfizer Inc
Novartis
Beta-Cell NV
ViaCyte
Osiris Therapeutics
GalaxoSmithKline
Sanofi
Janssen Research & Development
BioLineRx
Transition Therapeutics
Boehringer Ingelheim
PharmaCyte Biotech
Genentech
Novo Nordisk
Beta-O2 Technologies Ltd
In Chapter 6, on the basis of types, the Pancreatic Beta-Cell Protection market from 2015 to 2025 is primarily split into:
Stem Cell Based
Gene Therapies
RNA Based Therapies
Monoclonal Antibodies (MAbs)
Phytotherapy
In Chapter 7, on the basis of applications, the Pancreatic Beta-Cell Protection market from 2015 to 2025 covers:
Hospital
Medical Research Laboratory
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
